Valerie Chew
Valerie Chew
Translational Immunology Institute (TII)
Verified email at - Homepage
Cited by
Cited by
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ...
Gut 66 (2), 342-351, 2017
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ...
Gut 61 (3), 427-438, 2012
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ...
Journal of hepatology 52 (3), 370-379, 2010
Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ...
Gut 68 (5), 916-927, 2019
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
V Chew, L Lai, L Pan, CJ Lim, J Li, R Ong, C Chua, JY Leong, KH Lim, ...
Proceedings of the National Academy of Sciences 114 (29), E5900-E5909, 2017
Immune microenvironment in tumor progression: characteristics and challenges for therapy
V Chew, HC Toh, JP Abastado
Journal of oncology 2012, 2012
PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ...
Oncoimmunology 5 (3), e1085146, 2016
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
V Chew, YH Lee, L Pan, NJM Nasir, CJ Lim, C Chua, L Lai, SN Hazirah, ...
Gut 68 (2), 335-346, 2019
Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
EA Bard-Chapeau, AT Nguyen, AG Rust, A Sayadi, P Lee, BQ Chua, ...
Nature genetics 46 (1), 24-32, 2014
Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients
V Chew, C Tow, C Huang, E Bard-Chapeau, NG Copeland, NA Jenkins, ...
JNCI: Journal of the National Cancer Institute 104 (23), 1796-1807, 2012
Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond
YH Lee, D Tai, C Yip, SP Choo, V Chew
Frontiers in immunology 11, 568759, 2020
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ...
Nature communications 12 (1), 227, 2021
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
V Ho, TS Lim, J Lee, J Steinberg, R Szmyd, M Tham, J Yaligar, P Kaldis, ...
Oncotarget 6 (29), 27252, 2015
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ...
Journal for immunotherapy of cancer 8 (2), 2020
An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use
JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ...
Pathology 50 (3), 333-341, 2018
Expression of CD38 on macrophages predicts improved prognosis in hepatocellular carcinoma
JH Lam, HHM Ng, CJ Lim, XN Sim, F Malavasi, H Li, JJH Loh, K Sabai, ...
Frontiers in immunology, 2093, 2019
Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC
S Suthen, CJ Lim, PHD Nguyen, CA Dutertre, HLH Lai, M Wasser, ...
Hepatology 76 (5), 1329-1344, 2022
High-dimensional immune-profiling in cancer: implications for immunotherapy
S Chuah, V Chew
Journal for immunotherapy of cancer 8 (1), 2020
Leupaxin negatively regulates B cell receptor signaling
V Chew, KP Lam
Journal of Biological Chemistry 282 (37), 27181-27191, 2007
Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers
D Tai, SP Choo, V Chew
Cancers 11 (12), 1926, 2019
The system can't perform the operation now. Try again later.
Articles 1–20